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Abstract 
Objective: To investigate possible relationships between suicidal ideation and cerebrospinal 
fluid (CSF) levels of gliamarkers YKL-40 (also known as chitinase-3-like protein 1), growth-
associated protein-43 (GAP-43) and myelin basic protein (MBP).  
Method: The sample was obtained from the Prospective Population Study of Women and 
included 86 women without dementia who underwent both psychiatric examinations and 
lumbar puncture (LP). 
Results: Significantly higher CSF levels of both YKL-40 and GAP-43 were detected in 
women with past month suicidal ideation. Associations with suicidal ideation remained for 
both YKL-40 and GAP-43 in regression models adjusted for smoking status, BMI and age. 
CSF levels of YKL-40, GAP-43 and MBP did not differ by depression status. Higher levels of 
CSF GAP-43 were associated with feelings of worthlessness; a strong relationship was 
demonstrated in the fully adjusted model (OR 5.95 CI [1.52-23.20], P=0.01).  
Conclusion: Our findings of elevated CSF concentrations of both YKL-40 and GAP-43 in 
women with suicidal ideation, compared to those without, suggest that a disrupted synaptic-
glial functioning and inflammation may be related to the etiology of suicidal ideation in older 
adults. 
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Significant outcomes 
• In a population-based sample of women, higher CSF levels of GAP-43 and YKL-40    
   were observed in those with suicidal ideation, compared to those without.  
• Associations remained in models adjusted for smoking status, BMI and age.  
• Relationships could not be explained by depression status.  
 
Limitations    
• The sample consists of older adult women and cannot be extrapolated to other     
  populations.  
• Albeit the number of participants with CSF data being relatively large, the number of    
  cases with suicidal ideation was limited, reflecting the population-based study design. 
• The study design limits the possibility to draw conclusions about directionality since we    
 3
  have CSF data from one time point only and some of the women may have had episodes     
  of suicidal behavior prior to baseline.  
 
Introduction 
According to the World Health Organization, over 800 000 people die by suicide each year 
(1). High suicide rates are observed in older adults in most parts of the world, yet very little is 
known about the neurobiology of suicidal behavior in this age group (2). Being a serious 
health problem, the possibility of more quantitative and objective tools, such as biomarkers, 
for predicting and tracking suicidal states would be of clinical value.  
 A growing body of literature speaks for the involvement of inflammatory mediators in the 
pathophysiology of suicidal behavior in non-elderly cohorts (3, 4). The authors of a recent 
meta-analysis reviewed the literature on blood, CSF, and post mortem brain samples, 
highlighting robust associations between suicidality and IL-1β and IL-6 (5). The mechanisms 
of these associations remain to be elucidated. The role of microglial cells and astrocytes is of 
interest in this connection as the impact of cytokines on neurotransmitter storage and release 
by these cells are to a large extent involved in the general immunosurveillance and mediation 
of inflammation in the central nervous system (CSN) (6, 7). It has been suggested that 
abnormalities of proteins involved in neurotransmission and neural plasticity at synapses may 
be markers of dysregulated neural connectivity (8). At the same time, a dynamic interplay 
between neural and oligodendroglial mechanisms in regulating synaptic plasticity and 
sprouting has been shown when studying brain development and neural regeneration (9). 
Study of CSF microglial markers may help to shed light on neuropathological mechanisms 
associated with suicidality. One potential marker of interest is YKL-40, also known as 
chitinase-3-like protein 1 (CHI3L1), which has proven to be a very stable marker for 
monitoring inflammation and microglial activation in the CNS (10). To date, YKL-40 has 
been studied in the context of psychiatric morbidity in clinical samples with neurological 
disorders (11, 12). It has yet to be examined in relation to suicidal behavior. Growth 
associated protein 43 (GAP-43) is a marker of neuronal plasticity, critical to the regulation of 
neuronal morphology and communication where it plays an important role in neuronal 
sprouting, synaptic reorganization and alternation of neuronal morphology (13, 14). An early 
post-mortem study showed slightly increased levels of GAP-43 in the anterior frontal cortex 
of depressed persons who died by suicide (9). Further, abnormalities in the myelination 
process of these subjects was suggested by the finding of reduced myelin basic protein (MBP) 
immunoreactivity in that same study. MPB is found in oligodendrocytes and myelin sheets 
and plays an important role in neuroinflammatory processes leading to neuronal damage (15). 
MBP was recently highlighted as a biomarker of potential importance for the clinical 
prediction of suicide (16).  
 Many studies that examine relationships between CNS biomarkers and suicidal behavior are 
based on clinical cohorts with major depression. While associations between markers of 
inflammation and suicidal behavior might in part be explained by associations with 
depression (17, 18), differential results for affective disorders and suicidal behavior have been 
reported (19). Further, although major depression is the most common psychiatric disorder 
observed among persons who die by suicide, many of those who think about suicide or 
engage in suicidal behavior do not meet criteria for this condition. CSF biomarker studies 
using population-based cohorts can thus help to provide insights into neuropathological 
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mechanisms related to suicidal ideation in a broader context. To our knowledge, there are to 
date no studies examining relationships between CSF microglial markers and suicidal ideation 
in population-based samples.  
 
Aims of the study 
The aim of this study was to investigate associations between CSF markers (YKL-40, GAP-
43 and MBP) and suicidal ideation in a population-based sample of older women. A second 
aim was to test for relationships between these biomarkers and depression status. 
Materials and methods 
Subjects 
The study sample was obtained from the Prospective Population Study of Women (PPSW), a 
population-based survey in Gothenburg, Sweden (20). The sample was collected from the 
Swedish Population Register, based on birth date, and included women living in private 
households as well as those in residential care (20, 21). The study began in 1968-1969 and 
included a representative sample of 1462 women living in Gothenburg, Sweden born on 
certain dates in 1908, 1914, 1918, 1922 and 1930. In 1992-1993, 837 surviving women were 
invited to participate in a psychiatric examination and among those 591 who agreed to take 
part, 88 women aged 70-84 years consented to undergo a lumbar puncture (LP). Two of these 
women were diagnosed with dementia at the time of the LP. As higher values of CSF YKL-40 
have been associated with development of dementia (22) these women were excluded, leaving 
86 non-demented women born in 1908 (n=3), 1914 (n=7), 1918 (n=33), 1922 (n= 43) and 
1930 (n=1).  
No differences were observed between non-demented women with (n=86) and without 
(n=480) lumbar puncture with regard to age at examination, Mini Mental State Examination 
(MMSE) score, age at death, alcohol consumption, body mass index (BMI), systolic and 
diastolic blood pressure, levels of cholesterol in serum, level of education and smoking status 
(Supplementary Table 1). The proportion of women with major depression was numerically 
higher in the CSF group but the difference did not reach significance.  
 The study was approved by the Ethics Committee for Medical Research at the University of 
Gothenburg. Written informed consent was obtained from all participants at each examination 
wave. 
 
 
Procedures 
The clinical examination, which was carried out at a geriatric outpatient department or in the 
participant’s home, included comprehensive social, functional, physical, neuropsychiatric and 
neuropsychological examinations, as well as close informant interviews. Information about 
medication use was gathered at each study wave and classified according to the Anatomical 
Therapeutic Chemical Classification codes (ATC). The psychiatric examination was semi-
structured and performed by psychiatrists.  
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Diagnoses 
The Comprehensive Psychological Rating Scale (CPRS) (23) was used to rate psychiatric 
symptoms. The Montgomery Åsberg Depression Rating Scale (MADRS) (23), a subscale of 
the CPRS, was used to rate symptoms of depression. Ten symptoms are rated 0 (symptom not 
present) to 6 (severe symptom level). None of the women had scores indicating severe 
depression. Past month suicidal thoughts were assessed with the MADRS suicidality item, 
which employs the following anchor points: 0-1) Enjoys life or takes it as it comes. 2-3) 
Weary of life. Only fleeting death wishes. 4-5) Much better off dead. Suicidal thoughts are 
common, and suicide is considered as a possible solution, but without specific plans or 
intention. 6) Explicit plans for suicide when there is an opportunity. Active preparations for 
suicide. For the purpose of this study, a woman with a rating of 4-6 was considered to have 
suicidal ideation. Major depression was diagnosed in accordance with DSM-IV criteria (24) 
but the bereavement criterion was not applied, making the diagnosis compatible to DSM-5 
(25). Minor depression was diagnosed according to DSM-IV research criteria (either a sad or 
depressed mood or loss of interest or pleasures in nearly all activities, and in total at least 2 
but less than 5 additional symptoms). 
 
 
Neuropsychiatric examinations and interviews 
The exam included the MMSE (26) and tests of short- and long term memory, aphasia, 
apraxia, agnosia and abstract thinking. The diagnosis of dementia was made on the basis of 
the neuropsychological examination and the interview with the close informant, with each 
considered separately, using DSM-III-R criteria (27). Each symptom had to have reached a 
level at which it caused the subject substantial difficulty in social functioning and the duration 
of dementia had to be at least six months. A final diagnosis was made on the basis of the 
combined information. In the current study, dementia was an exclusion criterion only.   
 
CSF analysis 
Lumbar punctures were carried out in 1992-1993 and where CSF-samples (12 ml) were taken 
through the L3/L4 interspace and gently mixed to avoid gradient effects. The samples were 
promptly centrifuged at 2000g for 10 minutes to eliminate cells and other insoluble materials, 
aliquoted in 1 ml portions, snap frozen at -80 o C, stored at that temperature and brought in an 
unbroken freeze chain to the laboratory for analyses. The CSF samples in this study did not 
undergo any freeze thaw cycles prior to analysis. CSF YKL-40 concentrations were measured 
using the Human Chitinase 3-like 1 Quantikine ELISA Kit (R&D Systems, Minneapolis, 
MN). The intra-assay coefficient of variation was 3.3% and the inter-assay coefficient of 
variation was 9.1%. CSF GAP-43 was determined by ELISA (28). NM2 was used as 
capturing antibody, biotinylated NM4 as detecting antibody, and recombinant GAP-43 as 
standard. CSF MBP concentrations were measured using the Active® MBP ELISA kit 
(Diagnostic Systems Laboratories Inc., Webster, TX). The intra-assay coefficient of variation 
was 5.8% and the inter-assay coefficient of variation was 10.7%. All analyses were performed 
in one round of experiments using one batch of reagents by board-certified laboratory 
technicians who were blinded to clinical data.  
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Statistical analysis  
Differences in mean CSF levels of YKL-40, GAP-43 and MBP in by suicidal ideation were 
first tested with Student’s t-test. As associations might be impacted by smoking, BMI and 
age, binary logistic regressions were carried out adjusting for each of these variables, and 
results are then presented for fully adjusted models. F-tests were used for investigating 
differences in biomarker levels among those with no, minor and major depression.  
 In an explorative set of analyses, we used Fisher’s exact test to analyze relationships between 
the three CSF-markers and each of the specific symptoms included in the MADRS (with the 
exclusion of the suicide item): 1) Apparent sadness, 2) Reported sadness, 3) Inner tension, 4) 
Reduced sleep, 5) Reduced appetite, 6) Concentration difficulties, 7) Lassitude, 8) Inability to 
feel, and 9) Feelings of worthlessness. Binary logistic regressions were used to examine these 
associations while adjusting for smoking status, BMI and age. Statistical tests were carried out 
using SPSS for Windows (version 17, SPSS Chicago, IL.). All tests were two-tailed and 
significance was reported where P values were less than 0.05. 
 
Results 
Participant characteristics are presented in Table 1. Eight women reported past month suicidal 
ideation. As expected, these women scored higher on the MADRS. MMSE scores were 
similar in women with and without suicidal ideation. Table 1 shows further mean values for 
the investigated CSF-markers. Levels of both YKL-40 and GAP-43 were significantly higher 
in women with past month suicidal ideation. Levels of MBP were similar in women with and 
without such ideation. 
 
 
 
 
Table 1. Participant characteristics and CSF biomarkers by suicidal ideation in a population-
based sample of older women without dementia  
  
MADRS, Montgomery-Åsberg Depression Scale 
MMSE, Mini Mental State Examination 
 
Results of the binary regression models are shown in Table 2. The relationship between YKL-
40 and suicidal ideation remained in the model adjusted for age, smoking and BMI. A one 
unit increase in GAP-43 was associated with a more than four-fold increase in odds of 
suicidal ideation in the fully adjusted model. 
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Table 2. CSF biomarker associations with suicidal ideation from logistic regression models 
with smoking status, BMI and age in a population-based sample of older women without 
dementia 
  
 
We could not test for associations between CSF markers and ongoing medication due to 
limited study power.  Five women were on antidepressants and two of these had suicidal 
ideation. One woman (without suicidal ideation) had ongoing antipsychotic treatment. Anti-
inflammatory medication was currently prescribed to eight women, none of whom reported 
suicidal ideation. Finally, one woman with suicidal ideation had ongoing cortisone treatment.  
As previously reported (17), one fifth of the women fulfilled criteria for depression (major 
depression, n=10, minor depression, n=9). As presented in Table 3, CSF levels of YKL-40, 
GAP-43 and MBP did not differ by depression status.  
 
Table 3. Characteristics and CSF biomarkers by depression status in a population- 
based sample of older women without dementia (n=86) 
  
 
We also tested whether a “dose-response” relationship might be observed for any of the three 
CSF markers in relation to depression severity level as measured by the MADRS severity 
groups: no depression (0-12), mild depression (13-19) and moderate depression (20-34), but 
no such association could be observed (data not shown). 
 
In a set of exploratory analyses, relationships were tested between each of the CSF markers 
and each of the 9 other (non-suicide) MADRS items. As shown in Table 4, relationships could 
be shown for neither YKL-40 nor MBP.  
 
 
Table 4. CSF biomarkers by MADRS items in a population-based sample of older women 
without dementia (n=86)  
  
*p<0.05 using Student's t-test. 
 
Higher levels of CSF GAP-43 were associated with feelings of worthlessness; a strong 
relationship was demonstrated in a binary logistic regression model that included age, 
smoking status and BMI (OR 5.95 CI [1.52-23.20], P=0.01).  
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Discussion 
We found higher CSF levels of both GAP-43 and YKL-40 in women with suicidal ideation 
compared with those without such thoughts. To our knowledge, this is the first population-
based study to show findings suggesting that disrupted synaptic-glial functioning and 
inflammation may be related to the etiology of suicidal ideation in older adults. Also, our data 
suggest that the elevation of CSF YKL-40 and GAP-43 seen in women with suicidal ideation 
was not directly mediated by depression status. The impact of age on associations between the 
CSF markers and suicidal ideation appeared greater for age than for smoking status and BMI, 
but associations with suicidal ideation remained in the fully adjusted model. The microglial 
marker YKL-40 has not been studied previously in the context of suicidal behavior and 
depression. Data are thus lacking for comparison. YKL-40 is a known marker of 
inflammatory processes and microglial activation (11) and we know from previous studies 
that inflammatory processes contribute to the pathogenesis of suicidal behavior (29, 30).  
 While not directly comparable, as we investigated suicidal ideation rather than suicide death, 
our findings showing elevated levels of GAP-43 in suicidal women point in the same 
direction as a previous study indicating a slightly increased GAP-43 immunoreactivity in 
depressed suicides (9). As GAP-43 is known to be involved in the maintenance of synapses 
and neuritic regeneration it may be regarded as a neurodegenerative marker - a sign of 
neurodegeneration (31). Our findings on elevated GAP-43 in suicidal women may indicate 
changes in neuronal structure, signaling that neuronal plasticity is either compromised or 
deficient in the presence of suicidality. However, there are conflicting results with another 
post mortem study showing decreased levels of GAP-43 in depressed suicides (32). Animal 
research suggests that elevated levels of GAP-43 might be related to antidepressant exposure 
(33). While our study lacked power to address this question, antidepressant treatment could 
not explain the elevated rates observed in the suicidal women, because few of these were on 
treatment.  
 No significant difference in MBP levels could be established in the current study. This needs 
to be tested in larger population-based samples. Reduced levels of MBP have previously been 
shown in patients with schizophrenia and depression who died by suicide (9), indicating 
abnormalities in the myelination state or process.  
 While no relationships could be shown for YKL-40 or MBP in the exploratory analyses 
involving the other MADRS items, an association was observed between higher levels of 
GAP-43 and feelings of worthlessness. Further correction for multiple testing could not be 
performed due to the small size of our sample but this result may nevertheless provide an 
interesting lead for further investigation. In a recent clinical study focusing on patients with a 
single complicated episode of major depression, worthlessness was the only depressive 
symptom that predicted future post remission suicide attempts (34).  
 
Strengths and limitations 
Results from the current study cannot be extrapolated to male populations. Males may show 
up to 10% higher levels of GAP-43 compared to females (14). In clinical samples, no 
correlations between age and expressions of GAP-43 or MBP have been detected (9, 14). The 
effect of age needs to be clarified, however, when it comes to older adult populations. In 
persons with Alzheimer’s disease (AD), decreased levels of GAP-43 are observed in the 
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prefrontal cortex and the hippocampus while increased levels are seen in the CSF (35), 
indicating synaptic degeneration or plasticity. It is possible that CNS GAP-43 may in the case 
of suicidal ideation be a marker of neurodegeneration of cortical areas (frontal-subcortical 
connectivity) that are also affected in AD. While established AD does not appear to be 
associated with increased risk of suicide (36), clinical studies suggest that cognition may be 
impaired in older adults with suicidal behavior (37), and further studies are needed to clarify 
possible mechanisms.  
 Strengths of the study include the population-based sample and the comprehensive 
neuropsychological examinations. The latter made it possible to exclude persons with 
dementia, and to diagnose both major and minor depression. Some limitations need to be 
addressed. The samples were stored for several decades and the long-term stability of the 
three biomarkers examined in our study is not known.  If changes did occur, this would be 
anticipated to decrease the likelihood of finding significant differences between subgroups 
with and without suicidal ideation. While the number of participants with CSF data is 
relatively large, the number of cases with suicidal ideation was limited, reflecting the 
population-based study design. Another important limitation is that we have CSF data from 
one time point only. Some of the women may have had episodes of suicidal behavior prior to 
baseline. We can thus not make conclusions about the directionality of the observed 
relationships. Finally, a common limitation in population-based studies is that there is an 
underlying risk of attracting those who may be healthier than the general public. This type of 
selection bias decreases the likelihood of finding significant differences. 
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